Form 4: Tenaya Therapeutics Executive Leone D. Patterson Acquires Shares and Stock Options

Leone D. Patterson, Chief Financial and Business Officer of Tenaya Therapeutics, acquired 35,000 shares of common stock and 205,000 stock options on February 23, 2024, according to a Form 4 filing.

Summary

• Leone D. Patterson, the Chief Financial and Business Officer of Tenaya Therapeutics, Inc., reported changes in beneficial ownership to the SEC.
• On February 23, 2024, Patterson acquired 35,000 shares of common stock through restricted stock units and 205,000 stock options.
• The restricted stock units were granted under the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan and will vest in installments starting August 15, 2024.
• The stock options, also granted under the 2021 Equity Incentive Plan, will vest monthly starting one month after the transaction date and expire on 02/22/2034.
• Following these transactions, Patterson directly owns 95,755 shares of Tenaya Therapeutics, Inc. common stock and 205,000 stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing indicating insider transactions, which can be interpreted as a sign of confidence, but it doesn't provide enough information to be overly positive.

Positives

• The acquisition of shares and stock options by a key executive could be seen as a positive sign, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's value and future prospects.

Stakeholder Impact

• Shareholders may view the insider's stock acquisition as a positive signal.

Key Dates